Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study
- PMID: 19246576
- PMCID: PMC2647692
- DOI: 10.2337/dc09-S203
Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study
Abstract
Objective: To report the prevalence and incidence of type 1 and type 2 diabetes among African American youth and to describe demographic, clinical, and behavioral characteristics.
Research design and methods: Data from the SEARCH for Diabetes in Youth Study, a population-based, multicenter observational study of youth with clinically diagnosed diabetes aged 0-19 years, were used to estimate the prevalence for calendar year 2001 (692 cases) and incidence based on 748 African American case subjects diagnosed in 2002-2005. Characteristics of these youth were obtained during a research visit for 436 African American youth with type 1 diabetes and 212 African American youth with type 2 diabetes.
Results: Among African American youth aged 0-9 years, prevalence (per 1,000) of type 1 diabetes was 0.57 (95% CI 0.47-0.69) and for those aged 10-19 years 2.04 (1.85-2.26). Among African American youth aged 0-9 years, annual type 1 diabetes incidence (per 100,000) was 15.7 (13.7-17.9) and for those aged 10-19 years 15.7 (13.8-17.8). A1C was >or=9.5% among 50% of youth with type 1 diabetes aged >or=15 years. Across age-groups and sex, 44.7% of African American youth with type 1 diabetes were overweight or obese. Among African American youth aged 10-19 years, prevalence (per 1,000) of type 2 diabetes was 1.06 (0.93-1.22) and annual incidence (per 100,000) was 19.0 (16.9-21.3). About 60% of African American youth with type 2 diabetes had an annual household income of <$25,000. Among those aged >or=15 years, 27.5% had an A1C >or=9.5%, 22.5% had high blood pressure, and, across subgroups of age and sex, >90% were overweight or obese.
Conclusions: Type 1 diabetes presents a serious burden among African American youth aged <10 years, and African American adolescents are impacted substantially by both type 1 and type 2 diabetes.
Figures





Similar articles
-
Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for Diabetes in Youth Study.Diabetes Care. 2009 Mar;32 Suppl 2(Suppl 2):S123-32. doi: 10.2337/dc09-S204. Diabetes Care. 2009. PMID: 19246577 Free PMC article.
-
Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study.Diabetes Care. 2009 Mar;32 Suppl 2(Suppl 2):S102-11. doi: 10.2337/dc09-S202. Diabetes Care. 2009. PMID: 19246575 Free PMC article.
-
Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.JAMA. 2014 May 7;311(17):1778-86. doi: 10.1001/jama.2014.3201. JAMA. 2014. PMID: 24794371 Free PMC article.
-
Twenty years of pediatric diabetes surveillance: what do we know and why it matters.Ann N Y Acad Sci. 2021 Jul;1495(1):99-120. doi: 10.1111/nyas.14573. Epub 2021 Feb 5. Ann N Y Acad Sci. 2021. PMID: 33543783 Free PMC article. Review.
-
Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.J Pediatr. 2000 May;136(5):664-72. doi: 10.1067/mpd.2000.105141. J Pediatr. 2000. PMID: 10802501 Review.
Cited by
-
Small Business Support Is Associated with the Quantity, Quality, and Usage of Youth Physical Activity Opportunities in Urban, Low-Income, African American Neighborhoods.J Urban Health. 2022 Dec;99(6):1104-1114. doi: 10.1007/s11524-022-00694-8. Epub 2022 Oct 12. J Urban Health. 2022. PMID: 36222975 Free PMC article.
-
Concordance of next generation sequence-based and sequence specific oligonucleotide probe-based HLA-DRB1 genotyping.Hum Immunol. 2015 Dec;76(12):939-44. doi: 10.1016/j.humimm.2015.07.235. Epub 2015 Aug 4. Hum Immunol. 2015. PMID: 26247828 Free PMC article.
-
Blood-based bioenergetic profiling is related to differences in brain morphology in African Americans with Type 2 diabetes.Clin Sci (Lond). 2018 Dec 5;132(23):2509-2518. doi: 10.1042/CS20180690. Print 2018 Dec 12. Clin Sci (Lond). 2018. PMID: 30401689 Free PMC article.
-
Flexible Lifestyles for Youth (FL3X) behavioural intervention for at-risk adolescents with Type 1 diabetes: a randomized pilot and feasibility trial.Diabet Med. 2015 Jun;32(6):829-33. doi: 10.1111/dme.12641. Epub 2014 Dec 30. Diabet Med. 2015. PMID: 25424501 Free PMC article. Clinical Trial.
-
The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease.Curr Opin Immunol. 2014 Dec;31:66-78. doi: 10.1016/j.coi.2014.09.008. Epub 2014 Oct 22. Curr Opin Immunol. 2014. PMID: 25458997 Free PMC article. Review.
References
-
- Pinhas-Hamiel O, Zeitler P: The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 146 :693 –700,2005 - PubMed
-
- Liese AD, D'Agostino RB Jr, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B, Linder B, Marcovina S, Rodriguez B, Standiford D, Williams DE: The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118 :1510 –1518,2006 - PubMed
-
- Egede LE, Gogo-Jack S: Epidemiology of type 2 diabetes: focus on ethnic minorities. Med Clin North Am 89 :949 –975, viii, 2005 - PubMed
-
- Crook ED, Patel SR: Diabetic nephropathy in African-American patients. Curr Diab Rep 4 :455 –461, 2004 - PubMed
-
- Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21 :518 –524,1998 - PubMed
Publication types
MeSH terms
Grants and funding
- M01RR00037/RR/NCRR NIH HHS/United States
- U01 DP000247/DP/NCCDPHP CDC HHS/United States
- M01 RR000069/RR/NCRR NIH HHS/United States
- M01 RR01070/RR/NCRR NIH HHS/United States
- M01 RR000037/RR/NCRR NIH HHS/United States
- U01 DP000244/DP/NCCDPHP CDC HHS/United States
- M01 RR001271/RR/NCRR NIH HHS/United States
- M01 RR08084/RR/NCRR NIH HHS/United States
- M01 RR00069/RR/NCRR NIH HHS/United States
- PA 00097/PHS HHS/United States
- M01 RR001070/RR/NCRR NIH HHS/United States
- U01 DP000250/DP/NCCDPHP CDC HHS/United States
- M01RR001271/RR/NCRR NIH HHS/United States
- U01 DP000245/DP/NCCDPHP CDC HHS/United States
- DP-05-069/DP/NCCDPHP CDC HHS/United States
- M01 RR008084/RR/NCRR NIH HHS/United States
- U01 DP000248/DP/NCCDPHP CDC HHS/United States
- U01 DP000246/DP/NCCDPHP CDC HHS/United States
- U01 DP000254/DP/NCCDPHP CDC HHS/United States